Skip to main content
BACK TO BLOG HUB
Pharmacovigilance 11 min read Published 2026-10-18

Inside Arzon's Pharmacovigilance Curriculum: What Will You Learn in 12 Weeks?

Before enrolling in a pharmacovigilance course, ask a better question than 'Will I get a certificate?' Ask: 'What will I actually know and be able to practise when I finish?' Here is a week-by-week walkthrough of Arzon's Drug Safety Associate learning path.

AUTHOR: Arzon Career Intelligence Group (Healthcare Life Sciences Curriculum & Research)
Inside Arzon 12-Week Pharmacovigilance Curriculum
EXECUTIVE SUMMARY & OPERATIONAL TAKEAWAYSARZON DOSSIER
  • Arzon's 12-week curriculum is built across 6 progressive modules covering end-to-end drug safety operations.
  • Students complete 10 mock ICSR cases booked, a 100-term MedDRA coding drill (>95% accuracy), and a 50-case capstone PV dossier.
  • The curriculum strictly distinguishes workflow simulation and conceptual instruction from access to licensed production software.
  • Every module directly correlates with verified recruiter expectations at Global Capability Centers (Novartis, Pfizer) and CROs (IQVIA, Parexel, Cognizant, ICON).

1. Module 1: PV Foundations and Global Regulations (Weeks 1–2)

Before working through a drug safety case, you need to understand the fundamental purpose of pharmacovigilance and the global regulatory framework in which it operates. **Core Topics Covered:** - Drug development lifecycle and the clinical safety continuum (Phase I–IV). - Introduction to operational PV roles (Case Processor, Safety Reviewer, Aggregate Report Writer). - Good Pharmacovigilance Practices (ICH-GVP Modules I–XVI). - Statutory oversight by major regulatory authorities: US FDA (21 CFR 314.80), EMA, and India's CDSCO. - Essential safety terminology: Adverse Event (AE), Adverse Drug Reaction (ADR), and Serious Adverse Event (SAE). **What You Practise:** Analyzing real clinical safety scenarios, identifying statutory reporting triggers, and comparing regulatory frameworks across jurisdictions. **Practical Deliverable:** Regulatory comparison brief mapping FDA, EMA, and CDSCO expedited reporting mandates. **Why It Matters:** Recruiters test whether you understand *why* safety data is collected and how failure to report in accordance with GVP leads to severe regulatory sanctions.
Regulatory Milestone

Module 1 establishes the compliance foundation tested in the first 10 minutes of technical screening across multinational CROs.

2. Module 2: Adverse Events and ICSR Processing (Weeks 3–4)

Individual Case Safety Reports (ICSRs) represent the highest volume operational activity in global drug safety hubs. **Core Topics Covered:** - Triage criteria: Differentiating non-serious vs serious events based on statutory criteria (death, hospitalization, persistent disability, life-threatening, congenital anomaly). - Verification of the 4 mandatory ICSR elements: Identifiable Reporter, Identifiable Patient, Suspect Medicinal Product, and Adverse Reaction. - Source-document analysis: Reviewing hospital discharge summaries, clinical trial case reports, and spontaneous consumer emails. - Causality assessment algorithms: Applying the WHO-UMC causality categories and Naranjo probability scores. - Expectedness determination using the Reference Safety Information (RSI / SmPC Section 4.8). **What You Practise:** Working through structured mock cases, validating raw source information, identifying missing clinical details, and logging initial intake. **Practical Deliverable:** 10 mock ICSR cases booked and validated under simulated regulatory conditions. **Why It Matters:** Candidates must demonstrate how messy, real-world clinical reports are converted into structured, compliant safety records.

3. Module 3: MedDRA and WHO Drug Dictionary Concepts (Weeks 5–6)

Standardized medical dictionaries ensure that reported reactions and medicinal products are categorized consistently across global databases. **Core Topics Covered:** - MedDRA structural hierarchy: Navigating from System Organ Class (SOC) down through High Level Group Term (HLGT), High Level Term (HLT), Preferred Term (PT), to Lowest Level Term (LLT). - MedDRA Term Selection: Points to Consider (MTS:PTC) guidelines. - WHO Drug Dictionary (WHODD) concepts: Mapping commercial trade names to active substances and ATC codes. - Managing ambiguous verbatim terms, split coding, and combination therapies. - Quality control checks and identifying auto-encoding mismatches. **What You Practise:** Terminology coding exercises using de-identified medical transcripts and standardized coding rules. **Practical Deliverable:** 100-term medical coding assessment requiring >95% accuracy to clear quality review. **Why It Matters:** Interviewers frequently present tricky verbatim clinical terms and ask candidates to explain why a specific LLT was selected over an alternative.
Precision Coding Standard

Arzon assesses learners against industry audit thresholds: 95%+ precision on primary SOC and PT assignment is required for module sign-off.

4. Module 4: Safety Database Workflows and Case Documentation (Weeks 7–8)

Safety databases support the receipt, processing, evaluation, and electronic submission of safety cases. **Core Topics Covered:** - Safety database architecture: Intake windows, event tabs, product tabs, and regulatory submission routing. - Narrative writing: Drafting chronological, objective, and de-identified medical summaries. - Follow-up query workflows: Identifying missing medical information and tracking secondary reports. - Data quality review and automated discrepancy validation. - Electronic reporting workflows: Introduction to ICH E2B(R3) XML transmission logic. **Practical Deliverable:** Safety database simulation: 25 structured cases processed through simulated workflow milestones. **Software Access Transparency:** The programme clearly distinguishes conceptual instruction and simulated exercises from hands-on access to licensed systems such as Oracle Argus Safety or ARISg. Actual licensed software access is not implied unless explicitly included and confirmed in writing for your cohort. A student learns how the workflow operates and practises its logic without claiming production-system experience they do not have.
Software Access Notice

Workflows are taught through simulated case environments, de-identified datasets, and workflow demonstrations. Access to licensed enterprise production systems is not provided unless explicitly stated.

5. Module 5: Aggregate Reports and Signal Detection Fundamentals (Weeks 9–10)

Pharmacovigilance extends beyond single cases. Safety teams regularly aggregate data across thousands of reports to identify broader risk profiles. **Core Topics Covered:** - Regulatory purpose of aggregate reports: Periodic Safety Update Reports (PSUR), Periodic Benefit-Risk Evaluation Reports (PBRER), and Development Safety Update Reports (DSUR). - Medical literature surveillance: Screening biomedical databases (PubMed/Embase) for unpublished safety signals. - Signal detection fundamentals: Disproportionality analysis, qualitative vs quantitative signal evaluation. - Structured risk-benefit documentation and risk management plans (RMP). **What You Practise:** Reviewing line-listings, organizing aggregate data summaries, and drafting structured benefit-risk conclusions. **Practical Deliverable:** 1 mini-PSUR draft covering aggregate case review and signal screening for a model therapeutic agent. **Why It Matters:** Building aggregate report awareness demonstrates that you understand the broader product lifecycle and how individual ICSRs feed into global safety evaluations.

6. Module 6: Quality, Audits and Capstone Assessment (Weeks 11–12)

The final stage of the curriculum brings all operational competencies together and evaluates your inspection readiness. **Core Topics Covered:** - Quality management systems in PV: Quality control (QC) checks, error categorization, and audit trails. - Regulatory inspections: Understanding FDA Form 483 citations, EMA inspection findings, and audit observations. - Corrective and Preventive Actions (CAPA) implementation. - Technical interview preparation: Day-0 calculations, seriousness drills, and mock technical screenings. - Capstone assessment: Completing an end-to-end 50-case drug safety dossier. **What You Gain:** An audited, verifiable portfolio demonstrating the practical deliverables you completed throughout the programme. Exact deliverables, case counts, assessment criteria, and mentor review sessions are detailed in the current syllabus before enrolment.

7. How Does This Curriculum Relate to Employer Requirements?

Job descriptions across employers differ in seniority and tooling, but recurring operational themes govern entry-level hiring. Here is how Arzon's 12-week curriculum aligns with verified job requirements at Cognizant, ICON, IQVIA, and Parexel: - **Pharmacovigilance Foundations & GVP**: Mapped to **Module 1 (Weeks 1–2)**. Deliverable: Regulatory Comparison Brief. - **Case Intake, Triage & ICSR Workflow**: Mapped to **Module 2 (Weeks 3–4)**. Deliverable: 10 Mock ICSR Cases Booked. - **Standardized Terminology (MedDRA/WHODD)**: Mapped to **Module 3 (Weeks 5–6)**. Deliverable: 100-Term Coding Test (>95% Accuracy). - **Case Documentation & Database Concepts**: Mapped to **Module 4 (Weeks 7–8)**. Deliverable: Safety Database Simulation: 25 Cases. - **Aggregate Reports & Signal Fundamentals**: Mapped to **Module 5 (Weeks 9–10)**. Deliverable: 1 Mini-PSUR Draft. - **Quality Checks, Audits & Interview Readiness**: Mapped to **Module 6 (Weeks 11–12)**. Deliverable: Capstone 50-Case PV Dossier + Mock Interview. *Note: This mapping illustrates the educational alignment between syllabus topics and role requirements. Completing the curriculum does not substitute for employer-mandated prerequisites such as minimum university percentages, nor does it imply automatic employment.*

8. Who Is This Programme For?

The programme is designed for eligible graduates and final-year students from pharmacy and relevant life-sciences disciplines, including: - **B.Pharm & M.Pharm graduates** seeking entry into clinical research and pharmacovigilance operations. - **Pharm.D candidates** aiming for Drug Safety Associate, Medical Review, or Aggregate Reporting tracks. - **Life Sciences graduates (B.Sc / M.Sc Biotech, Microbiology, Biochemistry, BDS, MBBS)** transitioning into clinical trial safety. It is particularly suited if you want to: - Understand what a Pharmacovigilance Associate does on a day-to-day basis. - Build a structured foundation in ICSR workflows, MedDRA coding, and safety documentation. - Complete practical, case-based assignments that you can discuss during interviews. - Identify and bridge your technical skill gaps before applying to competitive vacancies. Before enrolling, confirm the eligibility criteria, delivery schedule, curriculum, fees, assessments, and mentor arrangements.

9. What Should You Expect After the Programme?

Upon completing the programme, you should expect to understand core pharmacovigilance operations and have completed the practical assignments specified for your track. Your subsequent steps include: - Refining your CV with verified project descriptions and deliverable summaries. - Practising technical screening questions and scenario-based interview walkthroughs. - Applying actively to entry-level vacancies across CROs, pharma GCCs, and IT healthcare operations. A completed training course is not the same as verified corporate production experience, and neither training nor placement assistance guarantees a job offer. Hiring decisions remain the sole prerogative of external employers based on your performance and current hiring needs.

10. Choose Training Based on What You Will Learn

The value of any training programme should be evaluated by its curriculum depth, the practical tasks you complete, the quality of mentor feedback, and its relevance to your career goals. At Arzon Careers, the Drug Safety Associate track provides a structured, transparent learning path across the core operations of pharmacovigilance. Review the programme information. Ask questions about the syllabus, fees, and deliverables. Make an informed decision based on what you will actually learn. ### Ready to review the details? - Explore the [Arzon Careers PV Associate Programme](/pv-associate). - Review our [Published Curriculum & Syllabus](/curriculum). - Connect the dots using our [What Employers Look for in PV Freshers Guide](/blog/pharmacovigilance-skills-employers-look-for).
VERIFIED COHORT PROGRAMME

Master Pharmacovigilance & Drug Safety Cohort at Arzon Global

Build audit-ready proof-of-work in software tools (Enterprise Safety Database, ICD-10-CM, Electronic Data Capture (EDC), eCTD, SAS) with 12 weeks of structured cohort training and cryptographic certificate verification.

Related Healthcare Career Intelligence

Pharmacovigilance

The 2026 Pharmacovigilance Career Guide: Enterprise Safety Database, Standardized Medical Coding & Fresher Salaries

An authoritative operational breakdown for Pharmacy, Medical, and Life Science graduates breaking into Drug Safety and Pharmacovigilance at Tier-1 GCCs and CROs.

READ DOSSIER →
Medical Coding

How to Break into Medical Coding in 2026: CPC Certification, ICD-10-CM & Salary Trends

Everything Life Science & Medical graduates need to know about AAPC CPC certification, ICD-10-CM/CPT coding guidelines, and securing medical coder jobs.

READ DOSSIER →
Clinical Data Management

Clinical Data Management (CDM) Careers 2026: Electronic Data Capture (EDC), Enterprise Life Sciences Cloud & CDISC SDTM

Discover how Clinical Data Managers build electronic case report forms (eCRFs), manage query resolutions, and structure clinical trial data for global regulatory approval.

READ DOSSIER →
WhatsApp counsellor